Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus May

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Hypertension (Dallas, Tex. : 1979)|November 29, 2017
Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and HypertensionStefan Engeli, Rudi Stinkens, Tim Heise, et al.
Neuron|January 26, 2011
The molecular and cellular identity of peripheral osmoreceptorsStefan G Lechner, Sören Markworth, Kate Poole, et al.
Frontiers in Psychiatry|December 16, 2020
The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic DisordersEwgeni Jakubovski, Anna Pisarenko, Carolin Fremer, et al.
BMC Medical Research Methodology|February 3, 2017
Motivations for (non)participation in population-based health studies among the elderly - comparison of participants and nonparticipants of a prospective study on influenza vaccinationManas K Akmatov, Leonhard Jentsch, Peggy Riese, et al.
Scientific Reports|March 8, 2019
Ultrafine particles and ozone perturb norepinephrine clearance rather than centrally generated sympathetic activity in humansKarsten Heusser, Jens Tank, Olaf Holz, et al.
Human Vaccines & Immunotherapeutics|April 11, 2017
Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general populationManas K Akmatov, Peggy Riese, Marcus May, et al.
The Lancet. Haematology|October 20, 2023
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 studyAndreas Tiede, Christina Hart, Paul Knöbl, et al.
Nature Communications|November 13, 2022
Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderlyPeggy Riese, Stephanie Trittel, Manas K Akmatov, et al.
Investigational New Drugs|January 20, 2018
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancerAndreas Schneeweiss, Tjoung-Won Park-Simon, Joan Albanell, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Hypertension (Dallas, Tex. : 1979)|November 29, 2017
Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and HypertensionStefan Engeli, Rudi Stinkens, Tim Heise, et al.
Neuron|January 26, 2011
The molecular and cellular identity of peripheral osmoreceptorsStefan G Lechner, Sören Markworth, Kate Poole, et al.
Frontiers in Psychiatry|December 16, 2020
The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic DisordersEwgeni Jakubovski, Anna Pisarenko, Carolin Fremer, et al.
BMC Medical Research Methodology|February 3, 2017
Motivations for (non)participation in population-based health studies among the elderly - comparison of participants and nonparticipants of a prospective study on influenza vaccinationManas K Akmatov, Leonhard Jentsch, Peggy Riese, et al.
Scientific Reports|March 8, 2019
Ultrafine particles and ozone perturb norepinephrine clearance rather than centrally generated sympathetic activity in humansKarsten Heusser, Jens Tank, Olaf Holz, et al.
Human Vaccines & Immunotherapeutics|April 11, 2017
Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general populationManas K Akmatov, Peggy Riese, Marcus May, et al.
The Lancet. Haematology|October 20, 2023
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 studyAndreas Tiede, Christina Hart, Paul Knöbl, et al.
Nature Communications|November 13, 2022
Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderlyPeggy Riese, Stephanie Trittel, Manas K Akmatov, et al.
Investigational New Drugs|January 20, 2018
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancerAndreas Schneeweiss, Tjoung-Won Park-Simon, Joan Albanell, et al.
Pageof 4